-
Mashup Score: 5
A philanthropic gift of a patient care coordinator designated to assist female bladder cancer patients in education, clinical decision-making, surveillance, support and even screening, is the first of its kind at Vanderbilt University Medical Center.
Source: Vanderbilt UniversityCategories: Latest Headlines, UrologyTweet
-
Mashup Score: 1BCAN TT 2022: Investigating Diet and Benefit from Immune Checkpoint Blockade in Urothelial Cancer - 2 year(s) ago
BCAN TT 2022 impact of diet on immune checkpoint inhibitor therapeutic response and tolerability in bladder cancer patients, BCAN Young Investigator Award, Immune checkpoint blockade (ICB), ICB response in patients with bladder cancer.
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet-
Investigating diet and benefit from immune checkpoint blockade in #UrothelialCancer. Presentation by @BrendanGuercio @WilmotCancer. #BCANTT22 written coverage by @pjhensley11 @universityofky on UroToday > https://t.co/0AkDpEzJcH @UroDocAsh @BladderCancerUS https://t.co/eKyKZ1oEg0
-
-
Mashup Score: 0BCAN TT 2022: Relationship of Circulating Tumor DNA in Patients with Muscle Invasive Bladder Cancer to Pathologic Staging and Disease Prognosis - 2 year(s) ago
BCAN TT 2022 role of ctDNA as a marker of pathologic response in patients with muscle invasive bladder cancer being treated with cisplatin-based neoadjuvant chemotherapy, Complete pathologic response (ypT0N0) after neoadjuvant chemotherapy, systematic endoscopic evaluation (SEE).
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet-
Relationship of circulating tumor DNA in patients with #MIBC to pathologic staging and disease prognosis. Presentation by @BenMironMD @FoxChaseCancer. #BCANTT22 written coverage by @pjhensley11 on UroToday > https://t.co/4cuVIcR1D0 @UroDocAsh @BladderCancerUS https://t.co/1AGzazUSRP
-
-
Mashup Score: 14
A philanthropic gift of a patient care coordinator designated to assist female bladder cancer patients in education, clinical decision-making, surveillance, support and even screening, is the first of its kind at Vanderbilt University Medical Center.
Source: Vanderbilt UniversityCategories: Latest Headlines, UrologyTweet-
https://t.co/p5tkpNCV7Z making the entire journey better for women w #bladdercancer #BCANTT22 @SUO_YUO @SWIUorg @AmerUrological @VUMCurology @VUMC_Cancer. Time to make real progress
-
-
Mashup Score: 5BCAN TT 2022: Targeting Urothelial Basal Cells in Transdifferentiation and Non-muscle Invasive Bladder Cancer - 2 year(s) ago
targeted transdifferentiation of the bladder urothelium, N-butyl-N-(4-hydroxybutyl)-nitrosamine (BBN) mouse model, Urothelial stem cells, urothelial and basal marker expression, KRT14 expressing stem cells, significance of EGFR inhibition with erlotinib, patients with NMIBC.
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet-
Targeting urothelial basal cells in transdifferentiation and non-muscle invasive #BladderCancer. Presentation by Kris Prado, MD on behalf of Philip Beachy, MD, PhD @Stanford. #BCANTT22 written coverage by @pjhensley11 > https://t.co/ifjgpT2G38 @UroDocAsh @BladderCancerUS https://t.co/vMWRJQxuno
-
-
Mashup Score: 0BCAN TT 2022: NRF2 Activation Promotes a Basal-like Phenotype but a Fitness Disadvantage in Normal Urothelium - 2 year(s) ago
NRF2 is a tumor suppressor, Activating mutations in NRF2 are common in bladder cancer, crucial role of NRF2 in normal urothelial differentiation, NRF2 promotes a fitness disadvantage, Fluorescent IHC, Nrf2 mutation.
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet-
NRF2 activation promotes a basal-like phenotype but a fitness disadvantage in normal urothelium. Presentation by Yuki Kita, MD, PhD @UNC_Lineberger. #BCANTT22 coverage by @pjhensley11 @universityofky. #ReadNow on UroToday > https://t.co/60Rj6HNdFo @UroDocAsh @BladderCancerUS https://t.co/C9fLOzRoJw
-
-
Mashup Score: 0
BCAN think tank 2022 CD40 receptor FcyRIIB engagement is required for optimal anti-CD40 agonistic activity, mutations in FcyRIIB have been found to further enhance anti-CD40 activity, Cluster differentiation 40 (CD40) is a stimulatory protein found on antigen-presenting cells which have been implicated in targeted cancer immunotherapies.
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet-
Defining and testing novel immunotherapy combinations for #NMIBC. Presentation by @DavidKnorrMDPhD on behalf of Jeffrey Ravetch, MD, PhD @MSKCancerCenter. #BCANTT22 written coverage by @pjhensley11 https://t.co/Vw85qfIod4 @UroDocAsh @BladderCancerUS https://t.co/OWndTzZMIp
-
-
Mashup Score: 5BCAN TT 2022: Factors Associated with Smoking Cessation: A Survey of Bladder Cancer Patient and Provider Perspectives on How to Quit - 2 year(s) ago
BCAN Think Tank 2022 2020 BCAN Patient-Centered Clinical Young Investigator Award, bladder cancer research on smoking cessation in bladder cancer patients, the understanding of patient and provider perspectives regarding smoking cessation, intervention for providers to promote smoking cessation.
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet-
Factors associated with smoking cessation: a survey of #BladderCancer patient and provider perspectives on how to quit. Presentation by @MattMossanen @BWHUrology. #BCANTT22 written coverage by @pjhensley11 > https://t.co/O1IIzZ88sF @DanaFarber @UroDocAsh @BladderCancerUS https://t.co/73SVIE86WH
-
-
Mashup Score: 4
BCAN Think Tank 2021 BCAN Patient-Centered Clinical Young Investigator Award, characterizing sexual function in females undergoing radical cystectomy, characterize changes in sexual function within one year following radical cystectomy in females
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet-
Sexual function in women undergoing radical cystectomy. Presentation by @Svet_MD @AlbanyMed. #BCANTT22 written coverage by @pjhensley11 @universityofky on UroToday > https://t.co/Pu3Aj2VSx8 @UroDocAsh @BladderCancerUS https://t.co/JmRSfvtSz1
-
-
Mashup Score: 0
BCAN Think Tank 2020 BCAN Young Investigator Award, B cells antigen-presenting cell (APC) heavily involved in immunogenicity, intratumoral B cell/CD8+ T cell (B8T) signature is associated with response to ICI in patients with advanced bladder cancer.
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet-
Gender-specific stratification of survival following immune checkpoint inhibitor therapy based on intratumoral expression of a B cell gene signature. Rusty Johnson, MD, PhD @HopkinsMedicine. #BCANTT22 coverage by @pjhensley11 > https://t.co/CtzAYvYmv7 @UroDocAsh @BladderCancerUS https://t.co/9uSHfB5PJ4
-
RT @UroCancerMD: https://t.co/p5tkpNCV7Z making the entire journey better for women w #bladdercancer #BCANTT22 @SUO_YUO @SWIUorg @AmerUrol…